Immunological and virological mechanisms involved in HIV-infection: Impact of the treatments;Mecanismes immunologiques et virologiques impliques dans l'infection a VIH: Impact des traitements

Revue du Praticien

Volumn 49, Issue 16, 1999, Pages 1740-1745

  Delfraissy, Jean François ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; INTERLEUKIN 2; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5;

CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTE DEPLETION; LYMPHOCYTIC INFILTRATION; OPPORTUNISTIC INFECTION; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION; AIDS RELATED COMPLEX; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIVISION; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; LYMPH NODE; PHYSIOLOGY; VACCINATION; VIROLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; HIV; HIV INFECTIONS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; LYMPH NODES; RECEPTORS, CCR5; VACCINATION; VIRUS REPLICATION;

EID: 0033569425     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Meyer L, Magierowska M, Hubert JB et al., and the SEROCO Study Group. Early protective effect of CCRS-Δ 32 heterozygosy on HIV-1 disease progression: relationship with viral load.AIDS 1997 ; 11 : F73-F78.
2. Misrahi M, Teglas J, N'Go N et al. for the French Pediatric HIV infection Study Group. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. JAMA1998 ; 279 : 277-280.
3. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993 ; 362 : 355-8.
4. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995 ; 373 : 123-6.
5. Wei X, Ghosh S.K, Taylor M.E. et al. Viral dynamics in human immunodeficiency virus type I infection. Nature 1995 ; 373 : 117-22.
6. Wolthers KC, Schuitemaker H, Miedema F. Rapid CD4T cell turnover in HIV-1 infection: a paradigm revisited. Immunonol Today 1998 ; 19 : 44-8.
7. Barker E, Mackewicz CE, Reyes-Teran G et al. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 1998 ; 92 : 3105-14.
8. Mellors JW, Munoz A, GioRgi JV et al. Plasma viral load and CD4 lymphocytes as the pronostic markers of HIV-1 infection. Ann Intern Med 1997 ; 126 : 946-54.
9. Zhang L, Ramratnam B, Tenner-Racz K et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 1999 ; 340 : 1605-13.
10. Furtado MR, Callaway DS, Phair JP et al. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 1999 ; 340 : 1614-22.
11. Finzi D, Blankson J, Siliciano JD et al. Latent infection of CD4+ cells provides a mechanism for lifelong persistence of HIV-1 even in patients on effective combination therapy. Nature Med 1999 ; 5 : 512-7.
12. Lambotte O, Taouflk Y, de Goer MG et al. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J AIDS 1999 (in press).
13. Autran B, Carcelain G, Li TS et al. Positive effects of combined antiretroviral therapy on CD4+T cell homeostasis and function in advanced HIV disease. Science 1997 ; 227 : 112-6.
14. Martinon F, Michelet C, Peguillet I et al. Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy. AIDS 1999 ; 13 : 185-94.
15. Levy Y, Capitant C, Houhou S et al. and the ANRS 048 study group. Subcutaneous IL-2 is equally efficacious and more convenient than intravenous IL-2 in asymptomatic HIV-infected patients: results of the ANRS 048 multicentric controlled trial. Lancet 1999 ; 353 : 1923-9.
16. Fauci AS. The AIDS epidemic. Considerations for 21st century. N Engl J Med 1999 ; 341 : 1046-50.